Skip to main content
Clinical Trials/NL-OMON20288
NL-OMON20288
Recruiting
Not Applicable

Detection of circulating tumour cells in cerebrospinal fluid (CSFCTs) to diagnose leptomeningeal metastases (LM) among breast cancer patientsa pilot study

Erasmus Medical Center0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
eptomeningeal metastases among breast cancer patients Nederlands:Leptomeningeale metastasen bij patienten met mammacarcinoom.
Sponsor
Erasmus Medical Center
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Breast cancer patients with clinical suspicion of leptomeningeal metastases (LM) who are planned to undergo a lumbar puncture to confirm/exclude the diagnosis LM.
  • \- Signed informed consent.

Exclusion Criteria

  • \- Contra\-indication for lumbar puncture (on the discretion of the treating neurologist).

Outcomes

Primary Outcomes

Not specified

Similar Trials